Board changes and COO appointment at Okairos
This article was originally published in Scrip
Executive Summary
T-cell vaccine specialist Okairos has appointed Bill Burns and Jean-Paul Prieels to its board of directors, and Tom Woiwode COO. Mr Burns, previously CEO of Roche's pharmaceutical division, will take the role of chairman. He and Mr Prieels, former head of research at GSK Vaccines, are replacing Thomas Szucs and Francesco Sinigaglia, who are both retiring. Mr Woiwode most recently served as COO of Euro Ventures.